期刊文献+

性别、年龄、肾功能、代谢参数及所患疾病对患者血清胱抑素C浓度的影响 被引量:3

Association of Sex,Age,Renal Function,Metabolic Index and Types of Diseases with Serum Cystatin-C in Patients
原文传递
导出
摘要 目的分析性别、年龄、肾功能、代谢参数和所患疾病对患者血清胱抑素C(Cys C)浓度的影响。方法收集2009年9~12月四川大学华西医院全部31235例住院患者首次检验记录,整理并采用多元线性回归分析其肾功能参数和代谢参数与血清Cys C浓度的关系;采用单因素方差分析和LSD检验分析不同系统疾病对患者血清CysC浓度的影响。结果多元回归方程为Cys C=0.331+0.686Crea+0.174Urea+0.119Age+0.068Uric-0.057HDL-C-0.041Sex+0.038eGFR-0.031LDL-C-0.026Glu;其复相关系数为0.859,决定系数为0.738。不同系统疾病组血清Cys C浓度的差异具有统计学意义(P<0.05),泌尿系统疾病组浓度最高,循环系统疾病组、呼吸系统疾病组次之。结论血清Cys C在临床检测中与患者肾功能相关性好,而与代谢参数相关性有待进一步深入研究;在有肾损害倾向的疾病中,血清Cys C浓度有增高的趋势。 Objective To identify the determinants of serum cystatin-C (Cys C) in patients. Methods The medical records of 31235 patients admitted to West China hospital from September to October, 2009 and their first laboratorial test results were examined. Liner regression analyses were performed to determine the association of sex, age, renal function, and metabolic index serum Cys C. One-way ANOVA and LSD tests were performed to determine the association between different diseases and serum Cys C. Results The multiple linear regression equation was obtained: Cys C = 0. 331 q-0. 686Crea -4-0. 174Urea q-0. llgAge + 0. 068Uric --0. 057HDL-C --0. 041Sex +0. 038eGFR --0. 031LDL-C --0. 026Glu, with a correlation coefficient of 0. 859 and a coefficient of determination of 0. 738. The level of serum Cys C varied with different diseases, with urinary diseases showing the highest level followed by vascular and respiratory diseases. Conclusion Serum Cys C is associated with renal function, but not with metabolic index. Cys C tends to rise in patients renal function injury.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期888-892,共5页 Journal of Sichuan University(Medical Sciences)
关键词 胱抑素C 肾功能 血糖 脂代谢 Cystatin-C Renal function Blood glucose Lipids metabolism
  • 相关文献

参考文献12

  • 1Groesbeek D, Kottgen A, Parekh R, etal. Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Soc Nephrol,2008;3(6) : 1777-1785.
  • 2Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the pre-eclamptic placenta. Mol Hum Reprod, 2007, 13(3) :49-55.
  • 3Westhuyzen J. Cystatin C: a promising marker and predictor of impaired renal function. Ann Clin Lab Sci, 2006336 (4) : 387- 393.
  • 4Shlipak MG, Praught ML, Sarnak MJ. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens, 2006 ; 15 (3) : 270-275.
  • 5Stabuc B, Vrhovec L, Stabuc-Silih M, et al. Improved prediction of decreased creatinine clearance by serum cystatin C:use in cancer patients before and during chemotherapy. Clin Chem,2000 ,46(2) : 193-197.
  • 6Kramer H, Palmas W, Kestenbaum B, et al. Chronic kidney disease prevalence estimates among racial/ethnic groups: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol, 2008, 3(5) : 1391-1397.
  • 7Weinert LS, Prates AB, do Amaral FB, et al. Gender does not iinfluence cystatin C concentrations in healthy volunteers. Clin Chem Lab Med,2010,48(3):405-408.
  • 8Kallner A, Ayling PA, Khatami Z. Does eGFR improve the diagnostic capability of S-Creatinine concentration results? A retrospective population based study. Int J Med Sci, 2008, 5 (1): 9-17.
  • 9Choe JY, Park SH, Kim SK. Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment. J Korean Med Sci, 2010; 25(1) :42-48.
  • 10Perkins BA, Nelson RG, Ostrander BE, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum eystatin C concentration:results of a 4-year follow-up study. J Am Soc Nephrol, 2005116(5) : 1404-1412.

同被引文献37

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部